M. Perry

发表

Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B.

J. Holland, J. Herndon, T. Ahles, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab.

H. Wakelee, J. Schiller, C. Langer, 2012, Lung cancer.

Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083.

J. Herndon, Mark R. Green, W. Eaton, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A multicenter, phase III randomized trial for stage IIIB/IV NSCLC of weekly paclitaxel and carboplatin vs. standard paclitaxel and carboplatin given every three weeks, followed by weekly paclitaxel.

C. Belani, W. Tester, D. Rinaldi, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study.

J. Herndon, D. Hollis, W. Eaton, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin in non-small cell lung cancer: an update on the Cancer and Leukemia Group B experience.

K. Propert, M. Green, G. Clamon, 1992, Seminars in oncology.

Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.

A. Korzun, J. Aisner, J. Holland, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study.

M. Green, J. Aisner, R. Carey, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832).

J. Herndon, D. Hollis, S. Luikart, 1997, American journal of clinical oncology.

A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer: a cancer and leukemia group B study.

J. Herndon, S. Luikart, C. Cirrincione, 1996, Lung cancer.

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.

K. Propert, R. Dillman, S. Seagren, 1990, The New England journal of medicine.

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

D. Spiegelman, W. Eaton, M. Green, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.

J. Ware, K. Propert, W. Eaton, 1987, The New England journal of medicine.

Phase I clinical evaluation of cytarabine and cisplatin in patients with advanced cancer.

R. Schilsky, M. Perry, J. Muscato, 1984, Cancer treatment reports.

Interleukin-2 activity in patients with extensive small-cell lung cancer: a phase II trial of Cancer and Leukemia Group B.

J. Herndon, M. Green, G. Clamon, 1993, Journal of the National Cancer Institute.

Carboplatin and vinblastine in advanced non-small-cell lung cancer: a phase II study

J. Herndon, M. Green, S. Graziano, 2004, Cancer Chemotherapy and Pharmacology.

A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.

S. Adak, R. Livingston, M. Perry, 2000, The New England journal of medicine.

The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer.

M. Vangel, R. Marks, R. Livingston, 2002, Lung cancer.

Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity.

M. Socinski, J. Herndon, E. Vokes, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.

R. Marks, K. Kelly, J. Herndon, 2005, Journal of Clinical Oncology.

A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.

K. Propert, V. Hirsh, J. Holland, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: a Cancer and Leukemia Group B Trial.

K. Propert, R. Weiss, M. Green, 1988, Medical and pediatric oncology.

Carboplatin/etoposide/paclitaxel in the treatment of patients with extensive small-cell lung cancer.

J. Herndon, M. Green, G. Clamon, 2001, Clinical lung cancer.

Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study.

L. Norton, W. Wood, R. Silver, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A study of filgrastim (rG-CSF) priming of etoposide/cisplatin in advanced non-small cell lung cancer.

J. Herndon, J. Crawford, S. Mehdi, 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.

M. Citron, J. Abrams, C. Cirrincione, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B.

J. Herndon, E. Vokes, M. Green, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

D. Berry, H. Parnes, L. Norton, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical evaluation of the neurophysins as tumor markers in small cell lung cancer.

W. North, L. H. Maurer, J. Ware, 1985, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer.

M. Green, G. Clamon, J. Crawford, 1997, Seminars in oncology.

Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B study.

J. Herndon, C. Cirrincione, M. Green, 1995, Lung cancer.

Neurophysins as tumor markers for small cell carcinoma of the lung: A cancer and leukemia group B evaluations

W. North, L. H. Maurer, J. Ware, 1988, Cancer.

Efficacy and safety of patupilone in non-small cell lung cancer (NSCLC): A phase I/II trial.

E. Felip, J. Hamm, P. Zatloukal, 2006, Journal of Clinical Oncology.

[A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer].

R. Livingston, G. Noël, J. Mazeron, 2001, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility

S. Huibner, B. Coburn, A. Mohammadi, 2020, Scientific Reports.